THERAPY OF MULTIDRUG-RESISTANT TUBERCULOSIS - LESSONS FROM STUDIES WITH MICE

被引:39
作者
KLEMENS, SP [1 ]
DESTEFANO, MS [1 ]
CYNAMON, MH [1 ]
机构
[1] VET ADM MED CTR,SYRACUSE,NY 13210
关键词
D O I
10.1128/AAC.37.11.2344
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of antituberculosis agents were evaluated in a murine tuberculosis model using a drug-resistant isolate. A multidrug-resistant clinical isolate from a recent outbreak of tuberculosis in the New York State correctional system was used for infection. Approximately 10(7) viable Mycobacterium tuberculosis ATCC 49967 (strain CNL) organisms were given intravenously to 4-week-old female outbred mice. Treatment was started 1 day after infection and given for 4 weeks. Spleens and lungs were homogenized, and viable cell counts were determined. Statistical analysis indicated that ethionamide, sparfloxacin, ofloxacin, capreomycin, clarithromycin, and clofazimine are active in the murine test system with this multidrug-resistant tuberculosis isolate. Sparfloxacin is the most active quinolone. Despite in vitro resistance, isoniazid has moderate activity. In vitro susceptibility data coupled with evaluation of agents against drug-resistant isolates in the murine system should provide information necessary to design clinical trials for treatment of infections with these organisms.
引用
收藏
页码:2344 / 2347
页数:4
相关论文
共 28 条
[1]  
ACHARYA BK, 1959, AM REV RESPIR DIS, V80, P871
[2]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[3]   TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CHAISSON, RE ;
SLUTKIN, G .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :96-100
[4]   THE EARLY BACTERICIDAL ACTIVITY OF RIFABUTIN MEASURED BY SPUTUM VIABLE COUNTS IN HONG-KONG PATIENTS WITH PULMONARY TUBERCULOSIS [J].
CHAN, SL ;
YEW, WW ;
MA, WK ;
GIRLING, DJ ;
ABER, VR ;
FELMINGHAM, D ;
ALLEN, BW ;
MITCHISON, DA .
TUBERCLE AND LUNG DISEASE, 1992, 73 (01) :33-38
[5]  
COLETSOS PJ, 1970, SCAND J RESPIR DIS S, V1, pS40
[6]  
CYNAMON MH, 1992, 1992 WORLD C TUB BET
[7]   DRUG-TREATMENT OF TUBERCULOSIS - 1992 [J].
DAVIDSON, PT ;
LE, HQ .
DRUGS, 1992, 43 (05) :651-673
[8]   INVITRO ACTIVITY OF NEW RIFAMYCINS AGAINST RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS AND MAIS-COMPLEX MYCOBACTERIA [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (03) :177-182
[9]   MULTIDRUG-RESISTANT TUBERCULOSIS [J].
DOOLEY, SW ;
JARVIS, WR ;
MARTONE, WJ ;
SNIDER, DE .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :257-259
[10]   CLINICAL PRESENTATION AND OUTCOME OF PATIENTS WITH HIV-INFECTION AND TUBERCULOSIS CAUSED BY MULTIPLE-DRUG-RESISTANT BACILLI [J].
FISCHL, MA ;
DAIKOS, GL ;
UTTAMCHANDANI, RB ;
POBLETE, RB ;
MORENO, JN ;
REYES, RR ;
BOOTA, AM ;
THOMPSON, LM ;
CLEARY, TJ ;
OLDHAM, SA ;
SALDANA, MJ ;
LAI, SH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :184-190